Cargando…
Bifidobacterium BLa80 mitigates colitis by altering gut microbiota and alleviating inflammation
This study was conducted to explore the therapeutic effect of the probiotic Bifidobacterium animalis subsp. lactis BLa80 on inflammatory bowel disease. A model of ulcerative colitis (UC) was induced in C57BL/6 mice by administering of 2.5% dextran sulphate sodium (DSS) for 8 days. After developing U...
Autores principales: | Dong, Yao, Liao, Wenyan, Tang, Jing, Fei, Teng, Gai, Zhonghui, Han, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174416/ https://www.ncbi.nlm.nih.gov/pubmed/35670877 http://dx.doi.org/10.1186/s13568-022-01411-z |
Ejemplares similares
-
Effects of Bifidobacterium BL21 and Lacticaseibacillus LRa05 on gut microbiota in type 2 diabetes mellitus mice
por: Gai, Zhonghui, et al.
Publicado: (2023) -
Fermented Glutinous Rice Extract Mitigates DSS-Induced Ulcerative Colitis by Alleviating Intestinal Barrier Function and Improving Gut Microbiota and Inflammation
por: Kim, Kwang-Youn, et al.
Publicado: (2023) -
Puerarin alleviates inflammation and pathological damage in colitis mice by regulating metabolism and gut microbiota
por: Zou, Yixin, et al.
Publicado: (2023) -
Early life administration of Bifidobacterium bifidum BD-1 alleviates long-term colitis by remodeling the gut microbiota and promoting intestinal barrier development
por: Peng, Chenrui, et al.
Publicado: (2022) -
The Gut Microbiota in Infants: Focus on Bifidobacterium
por: Solís, Gonzalo, et al.
Publicado: (2023)